|
⚲
|
| Keyboard |
| Rock Springs Capital Management LP | |
|---|---|
| Firm | |
| Address | 650 S Exeter Street Suite 1070 Baltimore, MD 21202 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Four Pines Offshore Fund LP | 021-364830 | Executive Officer | 24.0 M | ||
| Rock Springs Capital Offshore Fund LP | 021-294517 | Executive Officer | 1,057.0 M | ||
| Rock Springs Capital Management LP | |||||
| Four Pines Master Fund LP | 021-364824 | Executive Officer | 186.0 M | 311.1 M | |
| Rock Springs Capital Master Fund LP | 021-204603 | Executive Officer | 2,472.6 M | 2,115.2 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Xilio Therapeutics Inc XLO
Common Stock
|
2021-10-26 | Conversion | 756,472 | ||
|
Xilio Therapeutics Inc XLO
Series C Preferred Stock · derivative
|
2021-10-26 | Conversion | 7,186,490 | ||
|
Xilio Therapeutics Inc XLO
Series C Preferred Stock · derivative
|
2021-10-26 | Conversion | 1,437,297 | ||
|
Xilio Therapeutics Inc XLO
Common Stock
|
2021-10-26 | Buy | 500,000 | $16.00 | 8,000,000 |
|
Xilio Therapeutics Inc XLO
Common Stock
|
2021-10-26 | Conversion | 151,294 | ||
|
Theseus Pharmaceuticals Inc THRX
Series B Convertible Preferred Stock · derivative
|
2021-10-12 | Conversion | 349,320 | ||
|
Theseus Pharmaceuticals Inc THRX
Common Stock
|
2021-10-12 | Buy | 250,000 | $16.00 | 4,000,000 |
|
Theseus Pharmaceuticals Inc THRX
Common Stock
|
2021-10-12 | Conversion | 87,329 | ||
|
Theseus Pharmaceuticals Inc THRX
Common Stock
|
2021-10-12 | Conversion | 349,320 | ||
|
Theseus Pharmaceuticals Inc THRX
Series B Convertible Preferred Stock · derivative
|
2021-10-12 | Conversion | 87,329 | ||
|
Verve Therapeutics Inc VERV
Common Stock
|
2021-06-21 | Conversion | 556,298 | ||
|
Verve Therapeutics Inc VERV
Common Stock
|
2021-06-21 | Buy | 370,000 | $19.00 | 7,030,000 |
|
Verve Therapeutics Inc VERV
Common Stock
|
2021-06-21 | Conversion | 152,926 | ||
|
Verve Therapeutics Inc VERV
Series B Preferred Stock · derivative
|
2021-06-21 | Conversion | 1,416,023 | ||
|
Verve Therapeutics Inc VERV
Series B Preferred Stock · derivative
|
2021-06-21 | Conversion | 5,151,043 | ||
|
Atea Pharmaceuticals Inc AVIR
Series D Convertible Preferred Stock · derivative
|
2020-11-03 | Conversion | 178,063 | ||
|
Atea Pharmaceuticals Inc AVIR
Series D-1 Convertible Preferred Stock · derivative
|
2020-11-03 | Conversion | 104,340 | ||
|
Atea Pharmaceuticals Inc AVIR
Series D Convertible Preferred Stock · derivative
|
2020-11-03 | Conversion | 890,313 | ||
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2020-11-03 | Buy | 7,292 | $24.00 | 175,008 |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2020-11-03 | Buy | 242,708 | $24.00 | 5,824,992 |
| showing 20 of 38 most recent transactions | |||||